Keyword search (4,163 papers available)

"drug" Keyword-tagged Publications:

Title Authors PubMed ID
1 Editorial: Data-driven vaccine design for microbial-associated diseases Selvaraj G; Kaliamurthi S; Wei D; 41624882
CHEMBIOCHEM
2 Synthesis and Acidic pH-Responsive Disassembly of Dual-Location Shell-Sheddable/Core-Degradable Block Copolymer Nanoassemblies and Their Controlled Drug Delivery Andrade-Gagnon B; Casillas-Popova SN; Shamekhi M; Bairagi K; Peslherbe GH; Oh JK; 41524627
CHEMBIOCHEM
3 Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people London-Nadeau K; Barborini C; Haines-Saah R; Bazarov M; Bristowe S; Khorkhordina M; Lemay-Gaulin M; Gorka C; Juster RP; D' Alessio H; Chadi N; 40633507
PSYCHOLOGY
4 Stability of Acetals/Ketals Under Controlled Radical and Ring Opening Polymerization Andrade-Gagnon B; Casillas-Popova SN; Oh JK; 40614241
CHEMBIOCHEM
5 Repurposing Sigma-1 Receptor-Targeting Drugs for Therapeutic Advances in Neurodegenerative Disorders Eskandari K; Bélanger SM; Lachance V; Kourrich S; 40430519
CSBN
6 A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States Zolopa C; Clifasefi SL; Dobischok S; Gala N; Fraser-Purdy H; Phillips MK; Blackmore S; Wendt DC; 39970577
PSYCHOLOGY
7 Flow rate modulates focused ultrasound-mediated vascular delivery of microRNA He S; Singh D; Helfield B; 39850318
BIOLOGY
8 Effect of age on hypnotics' efficacy and safety in insomnia: A systematic review and meta-analysis Patrick Viet-Quoc N; Thien Thanh DV; Philippe L; Sebastien C; Lidia S; Philippe D; 39603114
CONCORDIA
9 Ion channel classification through machine learning and protein language model embeddings Ghazikhani H; Butler G; 39572876
ENCS
10 pH-Responsive Degradable Electro-Spun Nanofibers Crosslinked via Boronic Ester Chemistry for Smart Wound Dressings Casillas-Popova SN; Lokuge ND; Andrade-Gagnon B; Chowdhury FR; Skinner CD; Findlay BL; Oh JK; 38989606
BIOLOGY
11 Shear stress preconditioning and microbubble flow pattern modulate ultrasound-assisted plasma membrane permeabilization Memari E; Helfield B; 38988819
BIOLOGY
12 Exploiting protein language models for the precise classification of ion channels and ion transporters Ghazikhani H; Butler G; 38656743
CSFG
13 Learning from opioid withdrawal: Effects on striatal dopamine (Commentary on Ahn et al., 2023) Leyton M; Nikolic M; 38129315
CSBN
14 17β-Estradiol-Loaded Exosomes for Targeted Drug Delivery in Osteoporosis: A Comparative Study of Two Loading Methods Gholami Farashah MS; Javadi M; Soleimani Rad J; Shakouri SK; Asnaashari S; Dastmalchi S; Nikzad S; Roshangar L; 38022800
BIOLOGY
15 Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to anti-fungal compounds Dumeaux V; Massahi S; Bettauer V; Mottola A; Dukovny A; Khurdia SS; Costa ACBP; Omran RP; Simpson S; Xie JL; Whiteway M; Berman J; Hallett MT; 37888959
BIOLOGY
16 Modulation of cue value and the augmentation of heroin seeking in chronically food-restricted male rats under withdrawal Firas Sedki 37714221
CSBN
17 Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies Lu H; Hong T; Jiang Y; Whiteway M; Zhang S; 37307922
BIOLOGY
18 Efficacy of topical versus oral analgesic medication compared to a placebo in injured athletes: A systematic review with meta-analysis Nudo S; Jimenez-Garcia JA; Dover G; 37278322
CONCORDIA
19 Fluid flow influences ultrasound-assisted endothelial membrane permeabilization and calcium flux Memari E; Hui F; Yusefi H; Helfield B; 37150403
PHYSICS
20 Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease Nayak SS; Naidu A; Sudhakaran SL; Vino S; Selvaraj G; 37109050
CHEMBIOCHEM
21 Dual acting acid-cleavable self-assembling prodrug from hyaluronic acid and ciprofloxacin: A potential system for simultaneously targeting bacterial infections and cancer Ibrahim UH; Devnarain N; Mohammed M; Omolo CA; Gafar MA; Salih M; Pant A; Shunmugam L; Mocktar C; Khan R; Oh JK; Govender T; 36150574
CHEMBIOCHEM
22 Cytotoxicity and Genotoxicity of Azobenzene-Based Polymeric Nanocarriers for Phototriggered Drug Release and Biomedical Applications Londoño-Berrío M; Pérez-Buitrago S; Ortiz-Trujillo IC; Hoyos-Palacio LM; Orozco LY; López L; Zárate-Triviño DG; Capobianco JA; Mena-Giraldo P; 35956634
CNSR
23 Perfluorocarbon Nanodroplets for Dual Delivery with Ultrasound/GSH-Responsive Release of Model Drug and Passive Release of Nitric Oxide Choi M; Jazani AM; Oh JK; Noh SM; 35683912
CHEMBIOCHEM
24 Electrospun Upconverting Nanofibrous Hybrids with Smart NIR-Light-Controlled Drug Release for Wound Dressing Huang HY; Skripka A; Zaroubi L; Findlay BL; Vetrone F; Skinner C; Oh JK; Cuccia LA; 35019380
CHEMBIOCHEM
25 Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab Chertkow H; Rockwood K; Hogan DB; Phillips N; Montero-Odasso M; Amanullah S; Black S; Bocti C; Borrie M; Feldman H; Freedman M; Hsiung R; Kirk A; Masellis M; Nygaard H; Rajji T; Verret L; 34912492
PSYCHOLOGY
26 Imidazole-Mediated Dual Location Disassembly of Acid-Degradable Intracellular Drug Delivery Block Copolymer Nanoassemblies Jazani AM; Shetty C; Movasat H; Bawa KK; Oh JK; 34050688
CHEMBIOCHEM
27 Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ; 33968364
CERMM
28 Recent Advances of DNA Tetrahedra for Therapeutic Delivery and Biosensing. Copp W, Pontarelli A, Wilds CJ 33506614
CHEMBIOCHEM
29 Microfluidic Shear Processing Control of Biological Reduction Stimuli-Responsive Polymer Nanoparticles for Drug Delivery. Huang Y, Jazani AM, Howell EP, Reynolds LA, Oh JK, Moffitt MG 33455300
CHEMBIOCHEM
30 Osseointegration Pharmacology: A Systematic Mapping Using Artificial Intelligence Mahri M; Shen N; Berrizbeitia F; Rodan R; Daer A; Faigan M; Taqi D; Wu KY; Ahmadi M; Ducret M; Emami E; Tamimi F; 33181361
CONCORDIA
31 Controlled Microfluidic Synthesis of Biological Stimuli-Responsive Polymer Nanoparticles. Huang Y, Moini Jazani A, Howell EP, Oh JK, Moffitt MG 31820915
CHEMBIOCHEM
32 Direct Polymerization Approach to Synthesize Acid-Degradable Block Copolymers Bearing Imine Pendants for Tunable pH-Sensitivity and Enhanced Release. Hu X, Oh JK 32964550
CHEMBIOCHEM
33 Drug discovery and chemical probing in Drosophila. Millet-Boureima C, Selber-Hnatiw S, Gamberi C 32551911
BIOLOGY
34 Chronic Neuroleptic-Induced Parkinsonism Examined with Positron Emission Tomography. Galoppin M, Berroir P, Soucy JP, Suzuki Y, Lavigne GJ, Gagnon JF, Montplaisir JY, Stip E, Blanchet PJ 32353194
PERFORM
35 Hydrated electrons induce the formation of interstrand cross-links in DNA modified by cisplatin adducts Behmand B; Noronha AM; Wilds CJ; Marignier JL; Mostafavi M; Wagner JR; Hunting DJ; Sanche L; 32211848
CHEMBIOCHEM
36 Central ghrelin receptor stimulation modulates sex motivation in male rats in a site dependent manner. Hyland L, Rosenbaum S, Edwards A, Palacios D, Graham MD, Pfaus JG, Woodside B, Abizaid A 29080670
CSBN
37 Chemogenomic Profiling of the Fungal Pathogen Candida albicans. Chen Y, Mallick J, Maqnas A, Sun Y, Choudhury BI, Côte P, Yan L, Ni TJ, Li Y, Zhang D, Rodríguez-Ortiz R, Lv QZ, Jiang YY, Whiteway M 29203491
BIOLOGY
38 In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys. Chourey S, Ye Q, Reddy CN, Cossette C, Gravel S, Zeller M, Slobodchikova I, Vuckovic D, Rokach J, Powell WS 28476332
PERFORM
39 Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys. Reddy CN, Alhamza H, Chourey S, Ye Q, Gore V, Cossette C, Gravel S, Slobodchikova I, Vuckovic D, Rokach J, Powell WS 29339225
PERFORM
40 Adolescent media use and its association to wellbeing in a Canadian national sample. Fitzpatrick C, Burkhalter R, Asbridge M 31024788
PERFORM
41 Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry. Khalili-Mahani N, Rombouts SA, van Osch MJ, Duff EP, Carbonell F, Nickerson LD, Becerra L, Dahan A, Evans AC, Soucy JP, Wise R, Zijdenbos AP, van Gerven JM 28145075
PERFORM

 

Title:A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States
Authors:Zolopa CClifasefi SLDobischok SGala NFraser-Purdy HPhillips MKBlackmore SWendt DC
Link:https://pubmed.ncbi.nlm.nih.gov/39970577/
DOI:10.1016/j.drugalcdep.2025.112597
Publication:Drug and alcohol dependence
Keywords:Drug useHarm reductionIndigenous PeoplesScoping review
PMID:39970577 Category: Date Added:2025-02-20
Dept Affiliation: PSYCHOLOGY
1 Department of Educational and Counselling Psychology, McGill University, Montreal, QC, Canada. Electronic address: camille.zolopa@mail.mcgill.ca.
2 Harm Reduction Research and Treatment Center, University of Washington, Harborview Medical Center, Seattle, WA, USA.
3 Department of Educational and Counselling Psychology, McGill University, Montreal, QC, Canada; Clinical and Organization Support Team for Addiction and Homelessness, Notre-Dame Hospital, Montreal, QC, Canada.
4 Department of Educational and Counselling Psychology, McGill University, Montreal, QC, Canada; Department of Sociology & Anthropology, Concordia University, Montreal, QC, Canada.
5 Department of Educational and Counselling Psychology, McGill University, Montreal, QC, Canada.

Description:

Background: There is a great diversity of traditions, practices, and experiences among the Indigenous Peoples of North America and Oceania. However, Indigenous Peoples across these regions are affected by the historical and ongoing violence of settler colonialism, resulting in disproportionately heightened drug-related harms. 'Harm reduction' refers to both an ethos and a set of strategies intended to lessen negative social and/or health effects associated with drug use. While harm reduction could therefore be valuable to Indigenous people who use drugs, important concerns remain regarding the culturally specific implementation and outcomes of such strategies. A clearer picture of research regarding harm reduction in Indigenous communities is needed.

Method: We conducted a scoping review of primary studies regarding drug use harm reduction approaches among Indigenous communities in Australia, Canada, New Zealand, and the United States. We included studies that (1) reported on harm reduction principles or strategies; and (2) either reported disaggregated results for Indigenous participants or were based on a sample in which at least half of the participants identified as Indigenous. Medline and PsycINFO were searched in March 2024; screening by two independent reviewers was completed in April 2024.

Findings: Screening 578 references generated a corpus of 28 studies, 16 (57 %) of which were conducted in Canada. Indigenous people who use drugs generally reported favourable attitudes towards harm reduction initiatives; other community members and healthcare providers were more hesitant. A variety of harm reduction strategies were discussed, most commonly needle-syringe programs (n = 8, 29 %). Barriers included the availability and acceptability of harm reduction services. Community members expressed concerns regarding cultural appropriateness, but also offered possibilities for improved integration of harm reduction into Indigenous traditions and practices.

Interpretation: This review indicated an emerging, wide-ranging, and somewhat disparate body of literature. While barriers remain, there are promising possibilities for reconceptualizing harm reduction from an Indigenous ethos.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University